NCT05831787View on ClinicalTrials.gov

COVID19 OutcomeS in Myeloma and the Impact of VaCcines

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 23, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

January 31, 2025

Conditions
Multiple Myeloma
Interventions
OTHER

Patient Reported Outcomes

Patients will be asked to complete baseline, 30-day, and 6-month clinical and patient reported outcome health surveys.

Trial Locations (2)

10065

Memorial Sloan Kettering Cancer Center, New York

27514

UNC-Chapel Hill, Chapel Hill

Sponsors
All Listed Sponsors
collaborator

ModernaTX, Inc.

INDUSTRY

lead

ASH Research Collaborative

OTHER